NEW DELHI - India's biggest pharmaceutical company, Sun Pharmaceutical Industries Ltd., has announced it is developing a low-cost, potentially game-changing treatment for dengue that attacks all four strains of the virus and should be on pharmacy shelves within four years.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?